[144] Sera Prognostics, Inc. SEC Filing
Rhea-AI Filing Summary
Sera Prognostics' Form 144 shows a proposed sale of 7,094 Class A Common shares through Morgan Stanley Smith Barney on 08/08/2025. The filing states these shares were acquired by Restricted Stock Unit vesting on 08/08/2025 and lists an aggregate market value of 18,021 with 38,061,868 shares outstanding. The filing also discloses sales in the past three months: 5,132 shares on 05/08/2025 (gross proceeds 12,535) and 1,439 shares on 06/10/2025 (gross proceeds 2,136), totaling 6,571 shares sold for 14,671 gross proceeds. The notice includes the required representation that the seller does not possess undisclosed material adverse information.
Positive
- The shares to be sold were acquired by Restricted Stock Unit vesting, indicating no cash purchase for the acquisition.
- The proposed sale of 7,094 shares represents approximately 0.019% of the reported 38,061,868 shares outstanding, suggesting immaterial dilution.
Negative
- None.
Insights
TL;DR: Proposed 7,094‑share sale is small relative to the 38,061,868 shares outstanding (about 0.019%).
The Form 144 shows the 7,094 shares to be sold were acquired via RSU vesting on 08/08/2025 and are to be sold through Morgan Stanley Smith Barney on the same date. Relative to the reported 38,061,868 shares outstanding, the proposed sale represents approximately 0.019% of outstanding shares, indicating the transaction is immaterial from a dilution perspective. The filing also documents two prior sales in the last three months totaling 6,571 shares and aggregate gross proceeds of 14,671, which similarly represent a very small fraction of outstanding stock.
TL;DR: This is a routine insider sale tied to RSU vesting and includes the standard certification about undisclosed material adverse information.
The submission is a standard Form 144 disclosure for shares acquired by restricted stock unit vesting and slated for sale via a broker. The document contains the required seller representation that no undisclosed material adverse information is known. Given the small absolute size of the proposed sale versus total shares outstanding, the filing appears procedural rather than indicative of a material governance or disclosure concern.